Los dispositivos de visualización de Ambu se pueden utilizar para una amplia gama de procedimientos de vía aérea.
Existen estudios clínicos que documentan los beneficios de añadir equipos de visualización avanzados como herramienta indispensable para la gestión de la vía aérea.
aScope 4 Broncho y el videolaringoscopio King Vision son la opción ideal para todo tipo de intubaciónes.
Para superar el desafío de la colocación y el posicionamiento adecuado de los tubos de doble luz o de los bloqueadores endobronquiales, se recomienda el control visual como buena práctica clínica. Los productos de VivaSight hacen que la ventilación unipulmonar sea más rápida y efectiva, además de mejorar la seguridad del paciente.
Uno de los usos más comunes de la broncoscopia en la UCI es el manejo de las secreciones retenidas y la atelectasia. El control visual con un aScope 4 Broncho Large garantiza una eliminación eficaz y segura de la secreción sin riesgo de dañar la mucosa bronquial.
Leer más
Los pacientes críticamente enfermos con ventilación mecánica se enfrentan a una serie de riesgos durante su hospitalización en la UCI. El LBA es un excelente procedimiento para el diagnóstico oportuno y preciso. Pero, ¿siempre tiene acceso inmediato a un broncoscopio flexible cuando es necesario?
Leer más
El control visual con un broncoscopio durante la TDP mejora la seguridad del paciente. aScope 4 Broncho ofrece ventajas beneficiosas en cuanto a costes, ya que elimina todos los costes de reparación normalmente asociados con el uso de broncoscopios para TDP. Además, elimina el riesgo de contaminación cruzada.
El acceso limitado para formarse en intubación flexible y broncoscopia es un desafío actual debido a la falta de equipo y al miedo a dañar los sistemas de endoscopia costosos. Con aScope 4 Broncho, al ser un dispositivo de un solo uso, ya no tendrá que preocuparse por utilizar ese equipo y las reparaciones costosas y el reprocesamiento.
0 resultados
ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBPAGE BY AMBU A/S (THE “COMPANY”) IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY. THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS LOCATED IN THE UNITED STATES, CANADA, AUSTRALIA AND JAPAN AND ANY OTHER JURISDICTION WHERE THE EXTENSION OR AVAILABILITY OF THE PROPOSED OFFERING (AND ANY OTHER TRANSACTION CONTEMPLATED THEREBY) WOULD BREACH ANY APPLICABLE LAW OR REGULATION (THE “RESTRICTED JURISDICTIONS”).
Please read this notice carefully — it applies to all persons who view this webpage. Please note that the disclaimer set out below may be altered or updated from time to time. You should read it in full each time you visit the site.
Access to electronic versions of these materials is being made available by the Company in good faith and for information purposes only. Any person seeking access to this webpage represents and warrants to the Company that they are doing so for information purposes only. Making press announcements and other documents available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy the securities mentioned in such materials (the “Securities”). Further, it does not constitute a recommendation by the Company or any other party to sell or buy the Securities.
Viewing the materials on this webpage may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view such materials. Any citizens or residents or, or persons otherwise located in, any Restricted Jurisdiction, who wish to view these materials should satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so.
Unless otherwise determined by the Company and permitted by applicable law and regulation, the materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for the Securities by the Company made in the Restricted Jurisdictions or any other jurisdiction in which such offers or sales are unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
In particular, the Securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Securities will not be registered under or offered in compliance with applicable securities laws of any state, province, territory, county or jurisdiction of the United States or the other Restricted Jurisdictions. Accordingly, unless an exemption under the relevant securities law is applicable, the Securities may not be offered, sold, taken up, exercised, renounced, resold, delivered or distributed, directly or indirectly, in or into the United States or the other Restricted Jurisdictions or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration of the Securities in, such jurisdiction. There will be no public offering of the Securities in the United States.
If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
Electronic versions of these materials are not directed at or accessible by, nor should they be made available to, persons located in the Restricted Jurisdictions or in any other restricted jurisdiction.
By clicking on the “Agree” button, I certify that I am not located in any of the Restricted Jurisdictions or in any other restricted jurisdiction.
I have read and understood the disclaimer set out above. I understand that it may affect my rights. I agree to be bound by its terms. By clicking on the “Agree” button, I confirm that I am permitted to proceed to electronic versions of these materials.